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■ CASE REPORT ■
Introduction
During the past decade, the adoption of laparoscopic
myomectomy has offered the advantages of using min-
imally invasive surgeries. Nevertheless, repair of the
myometrium is difficult in the case of a large uterine
myoma. The da Vinci system (da Vinci® Surgical System,
Intuitive Surgical Inc, CA, USA) was cleared by the Food
and Drug Administration of the United States in July
2000 for laparoscopic surgeries. The instruments of this
surgical system provide surgeons with natural dexterity
and full range of motion for precise operation through
tiny incisions and offer an even greater range of motion
than the human hand. The da Vinci system takes surgical
precision and technique beyond the limits of the human
hand and allows for rapid and precise suturing, dis-
section and tissue manipulation which are standard
techniques for repair of the myometrium. We present
a woman with a large uterine myoma who underwent
laparoscopy-assisted robotic myomectomy.
Case Report
A 38-year-old, gravida 2, para 2, woman visited our
office with a chief complaint of lower abdominal pres-
sure and pain. A pelvic sonogram disclosed a subserosal
myoma with a broad base, measuring approximately
9 × 8 × 7 cm, which was located at the anterior uterine
wall. The patient insisted on preserving her uterus and
was concerned with the cosmetic results after the oper-
ation. She showed willingness to undergo myomectomy
using the newly developed robotic-assisted laparoscopic
system (da Vinci) and signed the consent form. A total
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SUMMARY
Objective: To report a case of a woman with a large uterine myoma who underwent laparoscopy-assisted robotic
myomectomy using the da Vinci system.
Case Report: A 38-year-old, gravida 2, para 2, female patient presented to our office with a chief complaint of
lower abdominal pressure and pain. A pelvic sonogram disclosed a subserosal myoma with a broad base, mea-
suring approximately 9 × 8 × 7 cm, which was located at the anterior uterine wall. The patient insisted on pre-
serving her uterus and was concerned with the cosmetic results after the surgery. She showed willingness to
undergo myomectomy using the newly developed laparoscopy-assisted robotic system (da Vinci) and signed the
consent form. The operation time was about 3 hours, with an estimated blood loss of 150 mL. The patient
passed flatus and resumed oral intake on the following day.
Conclusion: Minimally invasive surgery is the trend of the future. Robot-assisted laparoscopic surgery is a new
technique for myomectomy. This robotic system provides a three-dimensional operative field and an easy-to-use
control panel, which may be of great help when applying the suturing techniques and may shorten the learning
curve. More experience with and long-term follow-up of robotic surgery may be warranted to further validate the
role the robot-assisted approach in gynecologic surgery. [Taiwan J Obstet Gynecol 2007;46(2):174–176]
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da Vinci System for Laparoscopic Myomectomy
dose of 400 µg of misoprostol (Cytotec, 200 µg; GD
Searle, Chicago, IL, USA) was administered intrarectally
30 minutes before the surgery. Three trocar sites for the
da Vinci robotic system and one for the laparoscopic
instruments were used. After entering the peritoneal cav-
ity, diluted vasopressin (1:40; Pitressin, 20 U/mL;
Parke-Davis, Taiwan) was injected to the subserosa of
the myoma first, which provided a good hemostasis
and surgical field. The EndoWrist instrument (Intuitive
Surgical, California, USA) was controlled by a surgeon
at the console under a three-dimensional scope, and the
tenaculum forceps (Karl Storz, Tuttlingen, Germany)
was handled by an assistant. The myoma was extruded
using the “onion-skinning” technique (Figures A and B).
The wound of the myomectomy on the uterus was
repaired layer by layer by robotic suturing with 1-0 vicryl
(deepest layer) and 2-0 vicryl (seromuscularis layer) to
achieve good hemostasis (Figures C and D). The oper-
ation time was about 3 hours with an estimated blood
loss of 150 mL. The patient passed flatus and resumed
oral intake on the following day.
Discussion
Uterine myomas are the most common benign uterine
tumors. They are estimated to be present in at least 20%
of all women of reproductive age [1]. Hysterectomy has
long been considered as the definitive management 
of symptomatic uterine leiomyomas. For women who
wish to preserve their uterus, myomectomy is an alter-
native for these patients. Meticulous repair of the
myometrium to minimize the risk of uterine rupture is
essential for women considering pregnancy after laparo-
scopic myomectomy [2].
There were two reports on minimizing blood loss
during myomectomy. Vasopressin is effective in pre-
venting blood loss and reducing the need for blood
transfusion during myomectomy [3]. Vasopressin is a
standard procedure for myomectomy via laparotomy
or laparoscopy. Nevertheless, laparoscopy-assisted
robotic myomectomy requires skill and is not easy to do
in a short operating time, especially for large or multiple
myomas. Surgeons must have good suturing techniques
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Figure. Laparoscopic views of laparoscopy-assisted robotic myomectomy with da Vinci system. (A) The serosal layer of the
uterus is being dissected. (B) Myoma is extruded using the “onion-skinning” technique. (C) The myomectomy wound is
repaired layer-by-layer by robotic suturing with 1-0 and 2-0 vicryl, to achieve good hemostasis. (D) Completion of surgery.
Taiwan J Obstet Gynecol • June 2007 • Vol 46 • No 2176
S.P. Mao, et al
to shorten the operating time before the effects of
vasopressin start to wane. The da Vinci system allows
for an easy suturing technique. Some have reported
the need for a single preoperative dose of vaginal
misoprostol (400 µg), a simple and reliable method
for reducing intraoperative blood loss and reducing
the need for postoperative blood transfusion after
abdominal myomectomy [4]. With proven results of
the hemostatic effects of vasopressin and misoprostol,
we used vasopressin plus misoprostol in this case to
prolong the hemostatic effects and have a better view
of the surgical field.
The da Vinci three-dimensional vision offers superior
visualization and definition of the operative anatomy.
In addition to helping close dead space and prevent
hematoma formation, the EndoWrist technology
enhances the precision of the myomectomy and
decreases risk of perforation of the uterine cavity which
may predispose the patient to synechiae or a weak scar
with adenomyosis. According to Advincula et al [5],
robotic-assisted surgery may provide a way to improve
surgical training and the acquisition of advanced skills,
based on studies which evaluated the impact of robotic
technology for these purposes. Furthermore, robot-
assisted laparoscopic myomectomy is a promising new
technique that may overcome many of the surgical
limitations of conventional laparoscopy [5].
The main advantage of the system is the translation
of open surgical skills to laparoscopy. Despite recent
developments of basic tools (e.g. bipolar forceps) for
the da Vinci robot, the investment and maintenance
costs still have been the major limitations of the device.
Moreover, the device does not provide any haptic sense
(i.e. tactile feedback). Robotic surgery represents a turn-
ing point in surgical research. However, broad use of
robotic systems is limited mainly because of the high
investment and running costs [6]. The application and
efficacy of robotic gynecologic surgery remain to be
tested in large scale trials with long-term follow-up.
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